Cited by 242Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

Advances in technology for management of type 1 diabetes

Beck, Roy W, Bergenstal, Richard M, Laffel, Lori M, Pickup, John C·2019·The Lancet

Abstract

Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1 diabetes include insulin pumps, continuous glucose monitors, and, most recently, systems that combine both a pump and a monitor for algorithm-driven automation of insulin delivery. In the next 5 years, as many advances are expected in technology for the management of diabetes as there have been in the past 5 years, with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery. Expansion of the use of technology will be needed beyond endocrinology practices to primary-care settings and broader populations of patients. Tools to support decision making will also need to be developed to help patients and health-care providers to use the output of these devices to optimise diabetes management.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)31142-0

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

The citation lists haven’t been fetched yet

References 86 · Cited by 242

Authors
Beck, R. W., Bergenstal, R. M., Laffel, L. M., & Pickup, J. C.
Affiliations
  • Jaeb Center for Health Research (US)
  • Park Nicollet Health Services (US)
  • Joslin Diabetes Center (US)
  • Guy's Hospital (GB)
Corresponding author
Beck, Roy W
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-10
Volume
394
Issue
10205
Pages
1265-1273
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2972914641
Cited by
242
References
86
Citations by year
2026: 18 · 2025: 30 · 2024: 46 · 2023: 38 · 2022: 35 · 2021: 41 · 2020: 32
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Abbott Diabetes Care
  • Tandem Diabetes Care
  • Eli Lilly and Company
  • Roche
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, diabetes management, insulin pump, continuous glucose monitoring, artificial pancreas, blood glucose meters, primary care, decision support system
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 1, Humans, Insulin, Insulin Infusion Systems, Monitoring, Physiologic, Biomedical Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review